glp-1 and breast cancer risk GLP-1 weight loss drugs are being linked to lower breast cancer risk. Experts are optimistic about a possible breakthrough

For years, researchers have known that obesity is associated with an increased risk of developing and dying from several cancers, including breast cancer. At ASCO 2026, new studies examining GLP-1 receptor agonists

29.26

★★★★☆4.8 (126)

GLP-1 use is rising but what about #breastcancer risk? Long term safety matters. At #ASCO26, Elizabeth Susan McDonald, MD, PhD reported GLP-1 treatment was associated with lower BC incidence in women, but

26.22

★★★★★4.9 (98)

Could GLP-1 medications play a role in reducing breast cancer recurrence risk? In a story for Oprah Daily, Melinda Irwin, PhD, MPH, explains that weight management can improve inflammation, metabolism, immune function,

26.44

★★★★★5.0 (157)

The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer | Cancer and Metastasis Reviews

28.82

★★★★★4.7 (84)

The Impact and Safety of GLP‐1 Agents and Breast Cancer - Parsons - 2025 - Cancer Medicine

28.88

★★★★★4.9 (203)

GLP-1 Lower Breast Cancer Risk

27.12

★★★★★5.0 (176)

Is GLP-1 Safe for Breast Cancer Survivors? Evidence and Guidance – Bolt Pharmacy

23.61

★★★★★4.8 (132)